Qilian International Holding Group, Ltd.
NASDAQ:
QLI
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. Qilian’s products are sold in more than 20 provinces in China.
Key Facts
Auditor
Public Listing
Domicile
HQ/Management
Location of Key Operations
IR Contact
Friedman LLP
IPO (January 12, 2021)
Cayman Islands
Jiuquan, Gansu, China
Tina Xiao, Ascent IR
917-609-0333
Analyst Coverage
Latest News
July 9, 2021: Qilian International Holding Group Limited Enters into (globenewswire.com)
April 13, 2021: Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Drugs List
February 18, 2021: Qilian International Holding Group Limited CEO Receives Outstanding Entrepreneur Award
February 11, 2021: Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
February 8, 2021: Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
January 11, 2021: Qilian International Holding Group Limited Announces Pricing of Initial Public Offering